Assessing Ocular Surface Changes After Changing Glaucoma Medications

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
GlaucomaMonotherapy With Xalatan From 1 to 18 MonthsOcular Surface Disease
Trial Locations (1)

80045-0510

Rocky Mountain Lions Eye Institute, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT00554411 - Assessing Ocular Surface Changes After Changing Glaucoma Medications | Biotech Hunter | Biotech Hunter